New updates have been reported about LeanTaaS.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LeanTaaS has been named Best in KLAS 2026 for Capacity Optimization Management for the second consecutive year, solidifying its position as the only vendor ever to win this category and reinforcing its leadership in AI-driven hospital capacity management. The company’s iQueue platform posted a 95.6 score on KLAS’ 100-point scale with A+ marks for Culture, Loyalty, Relationship, and Value, and 100% of surveyed customers said they would repurchase, believe LeanTaaS keeps its promises, and view the firm as part of their long-term plans.
For health systems operating under margin pressure, workforce shortages, and reimbursement headwinds, LeanTaaS’ performance signals strong product-market fit and stickiness for its cloud-based capacity optimization suite. iQueue uses predictive and prescriptive analytics grounded in Lean principles to optimize operating rooms, inpatient beds, and infusion chairs, and is now deployed across nearly 200 health systems and more than 1,200 hospitals and centers, where customers report higher patient access, lower wait times, and improved financial results.
Founder and CEO Mohan Giridharadas framed the repeat award as validation that LeanTaaS is delivering measurable, recurring impact rather than one-off gains, positioning the platform as a de facto standard for capacity management in increasingly complex care environments. KLAS Research highlighted that client interviews consistently underscore the differentiated value from combining software with transformation services, and noted that no other vendor in the category has achieved Best in KLAS even once.
Customer testimonials cited in the report point to dependency on iQueue for day-to-day operations, with one executive stating that removing the system would leave their organization “dead,” underscoring the mission-critical nature of the tool. Other leaders emphasized that major EHR platforms still lag behind iQueue’s predictive analytics and interoperability capabilities, suggesting durable competitive advantage for LeanTaaS as health systems prioritize advanced capacity management over native EHR tooling.
This recognition enhances LeanTaaS’ commercial positioning in the hospital and health system segment, likely supporting new customer acquisition and expansion deals as capacity optimization becomes a C-suite priority. With validated customer satisfaction, strong renewal intent, and a growing installed base, LeanTaaS enters 2026 with reinforced credibility to drive further penetration of its AI-powered platform and deepen its role in customers’ operational and financial performance strategies.

